William Blair & Company
XENT

William Blair & Company’s Intersect ENT, Inc XENT Stock Holding History

William Blair & Company’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-5,700
Closed -$159K – 1545
2017
Q2 		$159K Buy
+5,700
New +$129K ﹤0.01% 1381

Other funds holding XENT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair & Company's XENT Position: Q3 2021 in Review

William Blair & Company sold out of Intersect ENT, Inc (XENT) in Q3 2021, closing a stake of 29,564 shares — an estimated $505K sold.

William Blair & Company first reported a position in XENT in Q2 2015 and held it in 25 quarters. The position peaked at $3.25M in Q3 2015. 123 funds tracked by Wall St. Rank hold XENT as of Q3 2021.

  • William Blair & Company reported no remaining Intersect ENT, Inc position as of Q3 2021 after selling out during the quarter.
  • William Blair & Company sold 29,564 Intersect ENT, Inc shares in Q3 2021, an estimated $505K.
  • William Blair & Company first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 25 quarters.
  • William Blair & Company's Intersect ENT, Inc position peaked at $3.25M in Q3 2015.
  • 123 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2021.

Based on William Blair & Company's 13F filing for Q3 2021, filed 12 Nov 2021.